Company intelligence / Profile preview

Preceptis Capital

Golden Valley, Minnesota, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Preceptis Medical has developed and commercialized the Hummingbird Tympanostomy Tube System (TTS), an FDA-cleared device that enables pediatric ear tube placement under conscious sedation rather than general anesthesia. Clinical studies, including a 250-child study published in a peer-reviewed journal, have demonstrated safety and efficacy. The technology is endorsed by the American Academy of Otolaryngology for in-office procedures and is gaining traction as a cost-saving alternative to traditional operating room-based surgery.

Therapeutic areas: OtherInfectious Diseases
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Montesy Helen (HK) Limited – investment and Chinese distribution partner

Beyond the preview

Go deeper on Preceptis Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preceptis Capital.

Explore the full profile